Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Southeast Asian J Trop Med Public Health ; 1991 Mar; 22(1): 77-80
Artículo en Inglés | IMSEAR | ID: sea-34087

RESUMEN

383 Thai soldiers on the Thai-Cambodian border were entered into a randomized malaria chemoprophylactic trial. Proguanil (200 mg/day) combined with sulfamethoxazole (1000 or 1500 mg/day) were compared to a standard combination of weekly pyrimethamine/dapsone (Maloprim). Men receiving proguanil/sulfamethoxazole had a significantly lower malaria attack rate than those taking pyrimethamine/dapsone. This was true of both the first five-week phase in which 1000 mg of sulfamethoxazole was used (0.11 vs 0.26; p less than 0.001) and in the second ten weeks in which 1500 mg of sulfamethoxazole was used (0.13 vs 0.30; p less than 0.001). Combined relative efficacy indicated that proguanil/sulfamethoxazole was better than pyrimethamine/dapsone by 64% for Plasmodium vivax and by 38% for P. falciparum. Unenforced compliance as measured by returned pills was greater than 86% in both groups. No serious drug side-effects were observed. Proguanil/sulfamethoxazole may represent a useful chemoprophylactic option in areas of multiple drug-resistant malaria.


Asunto(s)
Adulto , Animales , Cambodia , Proguanil/efectos adversos , Dapsona/efectos adversos , Resistencia a Medicamentos , Quimioterapia Combinada , Humanos , Malaria/prevención & control , Masculino , Personal Militar , Cooperación del Paciente , Plasmodium falciparum , Pirimetamina/efectos adversos , Sulfametoxazol/efectos adversos , Tailandia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA